Next Article in Journal
Lessons from Recent Measles Post-Campaign Coverage Surveys Worldwide
Previous Article in Journal
Safety and Immunogenicity of Intranasal Razi Cov Pars as a COVID-19 Booster Vaccine in Adults: Promising Results from a Groundbreaking Clinical Trial
Previous Article in Special Issue
SARS-CoV-2 Neutralization Assays Used in Clinical Trials: A Narrative Review
 
 
Editorial

Article Versions Notes

Vaccines 2024, 12(11), 1256; https://doi.org/10.3390/vaccines12111256
Action Date Notes Link
article xml file uploaded 5 November 2024 13:41 CET Original file -
article xml uploaded. 5 November 2024 13:41 CET Update https://www.mdpi.com/2076-393X/12/11/1256/xml
article pdf uploaded. 5 November 2024 13:41 CET Version of Record https://www.mdpi.com/2076-393X/12/11/1256/pdf
article html file updated 5 November 2024 13:42 CET Original file https://www.mdpi.com/2076-393X/12/11/1256/html
Back to TopTop